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becoming a public health emergency. In
Italy, first cases are reported from February
2020 and since then the virus has spread
quickly in all regions. On 11th March, World
Health Organization has declared Coronavirus disease 2019 (COVID-19) outbreak.
Coronavirus belongs to the Coronaviridae
family, Nidovirales order, and the 2019nCoV belongs to the β-coronavirus genus.1
Nowadays the elderly and those with underlying chronic diseases are more likely to
become severe cases. Thus far, all pediatric
cases in China with laboratory-confirmed
2019-nCoV infection were mild cases, and
no deaths had been reported.2
The transmission of the 2019-nCov
infection happened through the respiratory
droplets by infected patients, but coronavirus can also be transmitted by contact with
contaminated objects, such as phones, toys
and doorknobs3; however, also asymptomatic cases play a critical role in the transmission process.
Children are considered suspected
if they presented fever, cough, breathing
difficulties, gastrointestinal symptoms or
are related with a cluster outbreak or close
contact with 2019-nCoV infected/suspected
cases.
All pediatric suspected cases are isolated with only one parent in special single
rooms set up for sanitary emergency. It is
increasingly necessary to clean and disinfect
the articles used by little patients and their
caregivers.2
Besides various types of personal
protective equipment (PPE) are recommended and used by hospital healthcare
workers (HCWs) to protect from infection,
including high-filtration medical masks
such as FFP2 or FFP3, gloves, gowns, goggles and face shield. The protective equipment is disposable, and for each patient, it
is necessary to don and doff them about 5–6
times a day. The estimated average donning
time according to the correct procedures is
3–4 minutes, while the doffing time is about
1–2 minutes; however, the doffing phase is
the most dangerous because of the risk of
contamination. It has been reported that
about 15% of all HCWs become infected by
COVID-19 after 10 days of work in emergency department (ED), due to the contact
with the patients.
In this period, there is enormous
demands for PPE, especially medical
masks, used not only by HCWs but also by
all community. Therefore, on one side it is
important to reduce any unnecessary potential exposure to infection, but on the other
we must keep in mind the importance of
communication with patients and their caregivers, especially in a pediatric setting.

It is interesting to take inspiration from telemedicine, which uses a lot
of audio-video technologies to improve
patient health by facilitating interactions
between patients and clinicians or between
2 or more clinicians.4 Our hospital tried to
adapt to COVID-19 health emergency in
a short time. So, some dedicated rooms
to lockdown infected children, without an
interphone or telemetry system, were set
up, cameras were positioned inside, and
handheld transceivers (HTs) were given
to the parents for communication with the
HCWs. HTs let these interactions be synchronous, wherein parties engage in realtime, 2-way communication, without any
delay of time.
In this way, we significantly reduced
the number of clinical evaluations carried
out on the patient and therefore the use of
PPE, reducing exposure to potential infectious sources. We believe that HT can be
a useful tool both to save PPE and also to
protect HCWs during COVID-19 outbreak.
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To the Editors:

S

ARS-CoV-2, the RNA coronavirus etiologic agent of pneumonias that appeared
in December 2019 was sequenced and
confirmed in January 2020 by the Chinese
Center for Disease Control and Prevention.1
The World Health Organization on March
11 officially designated COVID-19 a pandemic as it spread rapidly to 196 countries
with over 54,000 confirmed cases in the
United States alone.2
While reports about the virus have
focused on the adult population, the largest study on children to date has been
reported from China by Dong et al. Their
clinical severity analysis, which included
both COVID-19-positive patients and those
with a high index of suspicion, revealed that
severe (ie, respiratory distress) and critical
(ie, ARDS or shock) occurred in 5.9% of
children compared with 18.5% in adults,
with infants below age one comprising the
highest proportion.3
We report a previously healthy, fully
vaccinated, late preterm, 58-day-old male
who presented with fever. On the day of
admission, he was sleeping longer than normal, had watery eye discharge with periorbital erythema and a rectal temperature of
101.2F. Stools were softer and greener for the
past 2 days. There was no respiratory distress,
cough, decreased intake, decreased frequency
of wet diapers, sick contacts, or travel.
Physical examination revealed T
100.8F (rectal), HR 176 beats per minute,
slight fussiness, glassy eyes with mild surrounding erythema, soft anterior fontanelle,
normal tympanic membranes bilaterally, and
mild nasal congestion. The rest of his examination was normal. Laboratory assessment
showed complete blood count : white blood
cells (WBC) 5.44 k/μL (normal: 4.0–19.5
k/μL) with 43% neutrophils (ANC 2497/μL;
normal: 1000–12,500/μL), 34% lymphocytes (ALC 1.86 k/μL, normal: 4.0–13.5),
10% monocytes, 10% eosinophils, 2.5%
reactive lymphocytes. Platelets 278 K/µL
(normal: 150–350 K/µL) and a mildly anemic
hemoglobin at 9.2 g/dL (normal: 9.4–11.2 g/
dL). Comprehensive metabolic panel was
normal except for a mildly elevated alkaline
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phosphatase and calcium. Urinalysis: 6 RBC,
23 white blood cells , no bacteria or leukocyte esterase. Blood culture and urine culture
were negative. Chest radiograph was normal.
Rapid flu, respiratory syncytial virus and
respiratory viral panel were negative, and a
COVID-19 test was performed. The patient
was treated with one dose of intramuscular
ceftriaxone and acetaminophen for fever.
Eighteen hours after admission, the
patient was afebrile, without further need
for antipyretics, with diminished periorbital
erythema and HR 140–149 beats per minute. He was discharged home with instructions to keep him and his family quarantined, pending his COVID-19 test results,
which came back positive 24 hours later.
The patient and his family remained well
after discharge.
This case demonstrates that presentation of COVID-19 is non-specific and easily attributed to many etiologies. Previous
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reports indicate that children with COVID19 have variable presentations including
asymptomatic, nausea, vomiting, diarrhea,
congestion, fever, dry cough, pneumonia,
fatigue, lymphopenia, and/or neutropenia.4
Despite being in the highest risk subgroup of children, the patient in this report
recovered within 24 hours of admission.
We conclude that during this new
pandemic, providers must consider COVID19 in infants presenting with fever and minimal other findings or historical risk factors.
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